BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (1992) 65, 697-700
© 1992 British Institute of Radiology
doi: 10.1259/0007-1285-65-776-697

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lammertsma, A. A.
Right arrow Articles by Jones, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lammertsma, A. A.
Right arrow Articles by Jones, T.

Low oxygen extraction fraction in tumours measured with the oxygen-15 steady state technique: effect of tissue heterogeneity

Adriaan A. Lammertsma, PhD and Terry Jones, DSc

MRC Cyclotron Unit, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK

Several reports have described decreased oxygen extraction fractions in tumours relative to those in normal tissues as measured with the oxygen-15 steady state technique and positron emission tomography. The present simulation study was carried out to assess the influence of tissue heterogeneity on these measured values. It was found that, within the range analyzed, tissue heterogeneity always resulted in underestimations of mean values of oxygen extraction fraction. It must, therefore, be concluded that the oxygen-15 steady state technique is not an accurate method for the assessment of the oxygen status of tumours. This finding should also apply to other pathological conditions, where a significant degree of tissue heterogeneity can not be excluded. More generally, this study demonstrates the need for detailed analyses of sensitivities of tracer kinetic procedures to tissue heterogeneity.

Key Words: Oxygen extraction fraction • Blood flow • Oxygen-15 steady state technique • Positron emission tomography • Simulation studies

Received for publication August 5, 1991. Revision received January 9, 1992. Accepted for publication February 11, 1992.




This article has been cited by other articles:


Home page
The OncologistHome page
A. J. de Langen, V. E. M. van den Boogaart, J. T. Marcus, and M. Lubberink
Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow
Oncologist, June 1, 2008; 13(6): 631 - 644.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
G R Laking and P M Price
Positron emission tomographic imaging of angiogenesis and vascular function
Br. J. Radiol., December 1, 2003; 76(suppl_1): S50 - S59.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. S. Herbst, N. A. Mullani, D. W. Davis, K. R. Hess, D. J. McConkey, C. Charnsangavej, M. S. O'Reilly, H.-W. Kim, C. Baker, J. Roach, et al.
Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin
J. Clin. Oncol., September 15, 2002; 20(18): 3804 - 3814.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. J. Hoekstra, S. G. Stroobants, O. S. Hoekstra, E. F. Smit, J. F. Vansteenkiste, and A. A. Lammertsma
Measurement of Perfusion in Stage IIIA-N2 Non-Small Cell Lung Cancer Using H215O and Positron Emission Tomography
Clin. Cancer Res., July 1, 2002; 8(7): 2109 - 2115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 1992 by the British Institute of Radiology.